Systems Biology, Systems Medicine, Systems Pharmacology: The What and The Why
Acta Biotheoretica · 2018-12 · 66 (4) · 345-365
DOI: 10.1007/s10441-018-9330-2 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Acta Biotheoretica, online erschienen am 09.05.2018. Verfasst von Angélique Stéphanou und 3 weiteren Autor:innen. Beteiligte Einrichtung: Université Grenoble Alpes, CNRS, TIMC-IMAG/DyCTIM2, 38000, Grenoble, France. angelique.stephanou@univ-grenoble-alpes.fr. Hauptthemen laut MEDLINE: Pharmacology, Precision Medicine, Systems Analysis, Systems Biology. Die Arbeit wurde bisher 49-mal zitiert (Crossref) und nennt 90 Literaturangaben.
Abstract (Originalsprache)
Systems biology is today such a widespread discipline that it becomes difficult to propose a clear definition of what it really is. For some, it remains restricted to the genomic field. For many, it designates the integrated approach or the corpus of computational methods employed to handle the vast amount of biological or medical data and investigate the complexity of the living. Although defining systems biology might be difficult, on the other hand its purpose is clear: systems biology, with its emerging subfields systems medicine and systems pharmacology, clearly aims at making sense of complex observations/experimental and clinical datasets to improve our understanding of diseases and their treatments without putting aside the context in which they appear and develop. In this short review, we aim to specifically focus on these new subfields with the new theoretical tools and approaches that were developed in the context of cancer. Systems pharmacology and medicine now give hope for major improvements in cancer therapy, making personalized medicine closer to reality. As we will see, the current challenge is to be able to improve the clinical practice according to the paradigm shift of systems sciences.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Université Grenoble Alpes, CNRS, TIMC-IMAG/DyCTIM2, 38000, Grenoble, France. angelique.stephanou@univ-grenoble-alpes.fr.
- Université Grenoble Alpes, CNRS, TIMC-IMAG/DyCTIM2, 38000, Grenoble, France.
- North Wales Cancer Centre, Betsi Cadwaladr University Health Board, Bangor, Denbighshire, UK.
- INSERM and Université Paris 11 Unit 935, Villejuif, France.
- University of Warwick, Coventry, UK.
Zitieren
APA
Stéphanou, A., Fanchon, E., Innominato, P. F., & Ballesta, A. (2018). Systems Biology, Systems Medicine, Systems Pharmacology: The What and The Why. Acta Biotheoretica, 66(4), 345-365. https://doi.org/10.1007/s10441-018-9330-2
Vancouver
Stéphanou A, Fanchon E, Innominato PF, Ballesta A. Systems Biology, Systems Medicine, Systems Pharmacology: The What and The Why. Acta Biotheoretica. 2018;66(4):345-365. doi:10.1007/s10441-018-9330-2
BibTeX
@article{Stphanou2018,
author = {Stéphanou, Angélique and Fanchon, Eric and Innominato, Pasquale F and Ballesta, Annabelle},
title = {Systems Biology, Systems Medicine, Systems Pharmacology: The What and The Why},
journal = {Acta Biotheoretica},
year = {2018},
volume = {66},
number = {4},
pages = {345--365},
doi = {10.1007/s10441-018-9330-2}
}
EUVIMED